Rationale and Design of the ‘MITOCARE’ Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
Atar, Dan, Abitbol, Jean-Louis, Arheden, Håkan, Berdeaux, Alain, Bonnet, Jean-Louis, Carlsson, Marcus, Clemmensen, Peter, Cuvier, Valerie, Danchin, Nicolas, Dubois-Rande, Jean-Luc, Engblom, Henrik, Erlinge, David, Firat, Huseyin, Jensen, Svend Eggert, Halvorsen, Sigrun, Hansen, Henrik Steen, Heiberg, Einar, Larsen, Alf-Inge, Le Corvoisier, Philippe, Longlade, Pascal, Nordrehaug, Jan Erik, Perez, Carole, Pruss, Rebecca, Sonou, Gilles, Schaller, Sophie, Tuseth, Vegard, Vicaut, Eric
Published in Cardiology (01.01.2012)
Published in Cardiology (01.01.2012)
Get full text
Journal Article